Beigene

SVB collapse: As biotechs report exposure to lender, US government moves to guarantee deposits and HSBC buys UK unit

13-Mar-2023 By Jane Byrne

Businesses and individuals that have money deposited with failed US bank Silicon Valley Bank (SVB) will be able to access all their cash from today, said the US government.

Hired and retired: New appointments in the biopharma industry

16-Aug-2022 By Rachel Arthur

Moderna, Curia and Abzena are among the companies welcoming new faces to top jobs.

BeiGene opens regional office in Basel to strengthen European presence

17-May-2022 By Rachel Arthur

BeiGene is opening a new regional office in Basel, Switzerland: with the location serving as the hub for the company’s operations in the region.

BeiGene gains commercial manufacturing approval for Guangzhou biologics facility

09-Apr-2021 By Rachel Arthur

BeiGene has announced approval from the China National Medical Products Administration (NMPA) to begin manufacturing its anti-PD-1 antibody, tislelizumab, at its biologics facility in Guangzhou, China.

Hired & Retired: Taking care of business

29-Jul-2020 By Ben Hargreaves

The industry plumps for business acumen, as companies seek to turn drug candidates from pipeline prospects to approved products.

BeiGene launches $2bn share offering, backed by Amgen

13-Jul-2020 By Ben Hargreaves

Chinese biotech plans to raise the sum as working capital, as it looks to progress its pipeline.

BeiGene receives nod for PD-1 treatment, Boehringer begins manufacture

07-Jan-2020 By Ben Hargreaves

BeiGene’s immunotherapy becomes its first treatment to receive approval in China and Boehringer announces that it has begun manufacture of the product.